Skip to main content
Premium Trial:

Request an Annual Quote

Geisinger to Use Ardais Biospecimen Management System

NEW YORK, July 6 (GenomeWeb News) - Pennsylvania-based health care provider Geisinger Health System will use the Ardais System biospecimen-management system in its cancer research programs, Ardais said today.


Geisinger will use the Ardais platform to collect, manage, and distribute clinically annotated biospecimens as part of a new research collaboration with the Windber Research Institute in which Geisinger will integrate its tissue-banking initiatives with Windber's molecular analytical capabilities.


The Ardais System will serve as the "backbone" of a clinically annotated biospecimen collection network for the collaboration, the company said.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.